These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5061636)

  • 1. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss.
    Halliday WJ
    Cell Immunol; 1972 Jan; 3(1):113-22. PubMed ID: 5061636
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
    Svoboda I; Măzuran R; Rabatić S; Silobrcić
    Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
    J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
    [No Abstract]   [Full Text] [Related]  

  • 5. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
    [No Abstract]   [Full Text] [Related]  

  • 6. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.
    Halliday WJ
    J Immunol; 1971 Mar; 106(3):855-7. PubMed ID: 5547301
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on immunity to autochthonous mouse tumors.
    Hellström I; Hellström KE; Pierce GE; Fefer A
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoregulating activity of tumor-associated macrophages.
    Dougherty GJ; McBride WH
    Cancer Immunol Immunother; 1986; 23(1):67-72. PubMed ID: 3464353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to sarcomas. A review.
    Weinert CR; McMaster JH; Ferguson RJ
    Clin Orthop Relat Res; 1974; (102):207-16. PubMed ID: 4529323
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey).
    Bubenik J; Turano A
    Nature; 1968 Nov; 220(5170):928-30. PubMed ID: 5722149
    [No Abstract]   [Full Text] [Related]  

  • 16. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of inflammation and sarcoma cell development in primary Moloney sarcoma-virus-induced tumors.
    Becker S; Haskill S
    Int J Cancer; 1981 Feb; 27(2):229-34. PubMed ID: 7287218
    [No Abstract]   [Full Text] [Related]  

  • 20. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
    Kadhim SA; Rees RC; Barrington-Leigh J
    Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.